Lartruvo
List of products in the National Drug Code with proprietary name lartruvo. This medication is used to treat a certain type of cancer (soft tissue sarcoma). Talk to your doctor about the benefits and risks of treatment with olaratumab. In Europe, this medication is being withdrawn from the market due to lack of effectiveness in a clinical study. This medication belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0002-7190 | Lartruvo | Eli Lilly And Company | ||||
0002-8926 | Lartruvo | Eli Lilly And Company |